CDIK
Medical Supernova Coming to Public Markets
Tuesday December 2, 9:00 am ET
GLAUCOMA with NO SURGERY: New Patent and New Medical Patented Procedure
BOCA RATON, FL--(MARKET WIRE)--Dec 2, 2003 -- There is a medical Public company, Coronado Industries (OTC BB: CDIK), coming to the markets with such financial force, the sheer size of the revenues from overseas will wake up the good investor to take advantage of the great stock price on this company.
Due to the tremendous honesty of the management team, the overseas market will show once again how much the U.S. needs new medical insight into new patented products and patented medical procedures. The genius of the corporate mindset enjoys bringing these types of amazing stories to the attention of the investor reader looking for ways in which to invest wisely. Buy low, sell high and enjoy your profit.
The public company, Coronado Industries (OTC BB: CDIK), offers a remarkable management team and research and development division. The world renowned CO-INVENTOR OF Radial Keratotomy is behind the newest medical buzz term, PNT. The mere mention of eye surgery to anyone sends everyone into a state of fear and panic. Make no mistake, what you are about to read will get your further attention. Please go to: www.coronadoindustries.com.
Coronado is a medical company with the tremendous vision and talent to match, to bring to the market overseas, a NO SURGERY process for GLAUCOMA, one of the most dreaded diseases of the eye. People will not have to live with fear for what they know is a problem until it is far too late for any doctor to help them. After all, tell the truth, don't people wait until the last moment to get medical help, just because of fear. Sometimes fear is a greater problem than the costs involved. Boy, there is one for the books. COST. Is the public around the world in for a shock? The cost for this procedure where there is no requirement for surgery will shock the countries around the world where people need this new medical procedure.
The target on this stock, CIDK, could be between $3.00 to $7.00 a share, shortly, with a very strong possibility of a buyout in approximately 2 year's or so at $15.00 to $17.00 a share, maybe more.
The marketplace loves medical advances and medical breakthrough firms. Get ready for some excitement from Coronado Industries.
Contact:
Contact:
C. Wilson
Economic Research Consultant
561-367-8545
cliff002003@yahoo.com, English
aleycamargo@yahoo.com, Spanish |
